<DOC>
	<DOCNO>NCT01958125</DOCNO>
	<brief_summary>The study look non-invasive treatment people suffer chronic episodic headache . Study subject randomize active treatment in-active treatment 2 week . After 2 week subject continue treat active treatment additional 2 week .</brief_summary>
	<brief_title>A Randomized Multicentre Study Acute Relief Episodic Chronic Cluster Headache .</brief_title>
	<detailed_description>The study prospective double blind , randomize , sham-controlled , multi-center investigation design comparison two parallel group , GammaCore® ( active treatment ) sham , ( in-active ) treatment . The study period begin 1-week run-in period , follow 2 week comparative period subject randomize ( 1:1 ) either active treatment sham ( in-active ) treatment . The comparative period follow open label 2 week period , subject sham treatment group switch treatment assignment receive active treatment active group continue receive active treatment .</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>Is 18 year old Has diagnose episodic chronic cluster headache accordance ICHD2 Classification criterion ( 2ndEd ) Is capable complete 5point pain scale , disability scale selfassessments Agrees refrain start new medication aim control cluster headache duration runin randomize phase Is able provide write Informed Consent 1 . Episodic cluster headache sufferer cluster headache bout time screen enrollment 2 . Need commence treatment oral injectable steroid eventual concomitant medical condition 3 . Has lesion ( include lymphadenopathy ) , dysaesthesia , previous surgery abnormal anatomy GammaCore® treatment site 4 . Is currently take medication indication CH opinion clinician may interfere study 5 . Has history cranial aneurysm , intracranial haemorrhage , brain tumour significant head trauma 6 . Diagnosed suspected secondary headache 7 . Has significant pain problem might confound study assessment opinion investigator 8 . Has know suspect severe atherosclerotic cardiovascular disease , severe carotid artery disease ( e.g . bruits history transient ischemic attack ( TIA ) cerebral vascular accident CVA ) , congestive heart failure ( CHF ) , know severe coronary artery disease recent ( 5 year ) myocardial infarction 9 . Has abnormal baseline ECG ( e.g . second third degree heart block , atrial fibrillation , atrial flutter , recent history ventricular tachycardia ventricular fibrillation , clinically significant premature ventricular contraction ) 10 . Has previous , cervical vagotomy 11 . Has uncontrolled high blood pressure 12 . Is currently implanted electrical and/or neurostimulator device , include limited cardiac pacemaker defibrillator , vagal neurostimulator , deep brain stimulator , spinal stimulator , bone growth stimulator , cochlear implant 13 . Has history carotid endarterectomy vascular neck surgery 14 . Has implant metal cervical spine hardware metallic implant near GammaCore stimulation site 15 . Has recent ( 12 month ) repeat history syncope 16 . Has recent ( 12 month ) repeat history seizure 17 . Has know history suspicion substance abuse addiction , overuse acute headache medication 18 . Has psychiatric cognitive disorder and/or behavioural problem opinion clinician may interfere study 19 . Is pregnant , nursing , think become pregnant next 6 week 20 . Is participate therapeutic clinical investigation participate clinical trial precede 30 day 21 . Is relative employee investigator clinical study site</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>vagus nerve stimulation</keyword>
	<keyword>vagal nerve stimulation</keyword>
	<keyword>nVNS</keyword>
	<keyword>VNS</keyword>
	<keyword>cluster headache</keyword>
	<keyword>non invasive</keyword>
	<keyword>gammacore</keyword>
</DOC>